Allergan and Kyorin Pharmaceutical Co., Ltd. Sign Exclusive Licensing Agreement to Develop and Market ALPHAGAN-R-/ ALPHAGAN-R- P in Japan.

Business Wire › May 26, 2004

Linked as:

Extract

Allergan and Kyorin Pharmaceutical Co., Ltd. Sign Exclusive Licensing Agreement to Develop and Market ALPHAGAN-R-/ ALPHAGAN-R- P in Japan.

Business Editors/Health/Medical Writers

IRVINE, Calif.--(BUSINESS WIRE)--May 26, 2004

Allergan, Inc. (NYSE:AGN) today announced that it has entered into an exclusive licensing agreement with Kyorin Pharmaceutical, Co., Ltd. (Kyorin) in Japan to develop and market the ALPHAGAN(R)/ ALPHAGAN...

See the full content of this document

Sponsored links

ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Language

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company

Other documents:

fitch rates desoto, texas' gos `aa-'. | Delta Air Lines Names Tom Lazour District Director - Civic and Promotional Affair... | Netgateway Names Roy W. Camblin III Chief Information Officer. | A Century of American Art and Culture. | decisión de juzgado tercero de los municipios mariño, garcia, tubores, villalba y peninsula de macanao de nue... | Sentencia nº 435 de Consiglio di Stato, January 30, 2008 | decisión nº 1333-10 de tribunal tercero de control de zulia extensión santa bárbara de december 17 2010 | decisión nº nâ°152-10 de tribunal sexto de ejecución de zulia (extensión maracaibo), de march 03, 201...